SCHEMBL5813192

SCHEMBL5813192

C/C(=N\NC(=O)c1cc(C)nc2ccc(F)cc12)c1ccc(O)c(O)c1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.50
ATM Q13315 1/20 0.50
KDM4E B2RXH2 5/20 0.49
ALDH1A1 P00352 4/20 0.49
HSD17B10 Q99714 1/20 0.49
L3MBTL1 Q9Y468 3/20 0.48
LMNA P02545 2/20 0.48
POLB P06746 2/20 0.48
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
MAPT P10636 3/20 0.46
MTOR P42345 1/20 0.44
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
TP53 P04637 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5813205 1.00 GAA (0.50) GAAATMKDM4EALDH1A1HSD17B10
SCHEMBL5812797 0.88 GAA (0.57) GAAATMKDM4EALDH1A1L3MBTL1
SCHEMBL5812773 0.88 GAA (0.57) GAAATMKDM4EALDH1A1L3MBTL1
SCHEMBL5814385 0.86 GAA (0.56) GAAATMKDM4EALDH1A1HSD17B10
SCHEMBL5809461 0.86 GAA (0.56) GAAATMKDM4EALDH1A1HSD17B10
SCHEMBL5809423 0.86 L3MBTL1 (0.65) GAAKDM4EALDH1A1L3MBTL1LMNA
SCHEMBL5809437 0.86 L3MBTL1 (0.65) GAAKDM4EALDH1A1L3MBTL1LMNA
SCHEMBL5813210 0.78 ATM (0.49) GAAATMKDM4EALDH1A1HSD17B10
SCHEMBL5813195 0.78 ATM (0.49) GAAATMKDM4EALDH1A1HSD17B10
SCHEMBL5813681 0.74 GAA (0.58) GAAKDM4EALDH1A1L3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006136008-A1 SALICYLIC ACID HYDRAZONES AS INHIBITORS OF THE ERK MAPKINASE PATHWAY AND FOR THE TREATMENT OF CANCER UNIVERSITY HEALTH NETWORK (CA) 2006-12-28 WO claimed
WO-2006136008-A1 SALICYLIC ACID HYDRAZONES AS INHIBITORS OF THE ERK MAPKINASE PATHWAY AND FOR THE TREATMENT OF CANCER UNIVERSITY HEALTH NETWORK (CA) 2006-12-28 WO disclosed